Ascendis Pharma Growth Disorders A/S

Ascendis Pharma Growth Disorders A/S (CVR number: 32323677) is a company from GENTOFTE. The company recorded a gross profit of -114185.7 kEUR in 2023. The operating profit was -114.2 mEUR, while net earnings were -120.2 mEUR. The profitability of the company measured by Return on Assets (ROA) was -40.8 %, which can be considered poor and Return on Equity (ROE) was -682.4 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -93.7 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. Ascendis Pharma Growth Disorders A/S's liquidity measured by quick ratio was 1894.6 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.